Corrigendum to “Investigation of 3-sulfamoyl coumarins against cancer-related IX and XII isoforms of human carbonic anhydrase as well as cancer cells leads to the discovery of 2-oxo-2H-benzo[h]chromene-3-sulfonamide – A new caspase-activating proapoptotic agent” [J. Med. Chem. 222 (2021) 113589] (European Journal of Medicinal Chemistry (2021) 222, (S0223523421004384), (10.1016/j.ejmech.2021.113589))

Standard

Corrigendum to “Investigation of 3-sulfamoyl coumarins against cancer-related IX and XII isoforms of human carbonic anhydrase as well as cancer cells leads to the discovery of 2-oxo-2H-benzo[h]chromene-3-sulfonamide – A new caspase-activating proapoptotic agent” [J. Med. Chem. 222 (2021) 113589] (European Journal of Medicinal Chemistry (2021) 222, (S0223523421004384), (10.1016/j.ejmech.2021.113589)). / Dar'in, Dmitry; Kantin, Grigory; Kalinin, Stanislav ; Sharonova, Tatiana; Bunev, Alexander; Ostapenko, Gennady I.; Nocentini, Alessio; Sharoyko, Vladimir; Supuran, Claudiu T.; Krasavin, Mikhail.

In: European Journal of Medicinal Chemistry, Vol. 225, 113788, 01.12.2021.

Research output: Contribution to journal › Comment/debate › peer-review

BibTeX

@article{5239166a73d347bdb7e68a9bcadc65a9,

title = "Corrigendum to “Investigation of 3-sulfamoyl coumarins against cancer-related IX and XII isoforms of human carbonic anhydrase as well as cancer cells leads to the discovery of 2-oxo-2H-benzo[h]chromene-3-sulfonamide – A new caspase-activating proapoptotic agent” [J. Med. Chem. 222 (2021) 113589] (European Journal of Medicinal Chemistry (2021) 222, (S0223523421004384), (10.1016/j.ejmech.2021.113589))",

abstract = "The authors regret to inform that a funding source was not properly acknowledged in the Acknowledgement section of this article. The correct Acknowledgement section should read as follows: “This research was supported by the Russian Science Foundation (project grant 21-73-20264). T.S. is grateful for the support from the Russian Foundation for Basic Research (project grant 19-33-90017). We are grateful to the Centre for Chemical Analysis and Materials Research of Saint Petersburg State University Research Park for the high-resolution mass-spectrometry data.” The authors would like to apologise for any inconvenience caused.",

author = "Dmitry Dar'in and Grigory Kantin and Stanislav Kalinin and Tatiana Sharonova and Alexander Bunev and Ostapenko, {Gennady I.} and Alessio Nocentini and Vladimir Sharoyko and Supuran, {Claudiu T.} and Mikhail Krasavin",

note = "Publisher Copyright: {\textcopyright} 2021 Elsevier Masson SAS",

year = "2021",

month = dec,

day = "1",

doi = "10.1016/j.ejmech.2021.113788",

language = "English",

volume = "225",

journal = "European Journal of Medicinal Chemistry",

issn = "0223-5234",

publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - Corrigendum to “Investigation of 3-sulfamoyl coumarins against cancer-related IX and XII isoforms of human carbonic anhydrase as well as cancer cells leads to the discovery of 2-oxo-2H-benzo[h]chromene-3-sulfonamide – A new caspase-activating proapoptotic agent” [J. Med. Chem. 222 (2021) 113589] (European Journal of Medicinal Chemistry (2021) 222, (S0223523421004384), (10.1016/j.ejmech.2021.113589))

AU - Dar'in, Dmitry

AU - Kantin, Grigory

AU - Kalinin, Stanislav

AU - Sharonova, Tatiana

AU - Bunev, Alexander

AU - Ostapenko, Gennady I.

AU - Nocentini, Alessio

AU - Sharoyko, Vladimir

AU - Supuran, Claudiu T.

AU - Krasavin, Mikhail

PY - 2021/12/1

Y1 - 2021/12/1

N2 - The authors regret to inform that a funding source was not properly acknowledged in the Acknowledgement section of this article. The correct Acknowledgement section should read as follows: “This research was supported by the Russian Science Foundation (project grant 21-73-20264). T.S. is grateful for the support from the Russian Foundation for Basic Research (project grant 19-33-90017). We are grateful to the Centre for Chemical Analysis and Materials Research of Saint Petersburg State University Research Park for the high-resolution mass-spectrometry data.” The authors would like to apologise for any inconvenience caused.

AB - The authors regret to inform that a funding source was not properly acknowledged in the Acknowledgement section of this article. The correct Acknowledgement section should read as follows: “This research was supported by the Russian Science Foundation (project grant 21-73-20264). T.S. is grateful for the support from the Russian Foundation for Basic Research (project grant 19-33-90017). We are grateful to the Centre for Chemical Analysis and Materials Research of Saint Petersburg State University Research Park for the high-resolution mass-spectrometry data.” The authors would like to apologise for any inconvenience caused.

UR - http://www.scopus.com/inward/record.url?scp=85113379826&partnerID=8YFLogxK

UR - https://www.mendeley.com/catalogue/c22586c3-c0e9-3cab-8c1f-84acf92aa1d4/

U2 - 10.1016/j.ejmech.2021.113788

DO - 10.1016/j.ejmech.2021.113788

M3 - Comment/debate

AN - SCOPUS:85113379826

VL - 225

JO - European Journal of Medicinal Chemistry

JF - European Journal of Medicinal Chemistry

SN - 0223-5234

M1 - 113788

ER -

ID: 85383083

Standard

Harvard

APA

Vancouver

Author

BibTeX

RIS